University of Washington
At Some Hospitals, Expert Panels Help Guide Anti-Amyloid Drug Decisions for Alzheimer's Patients
Premium
These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such programs are necessary.
Aston Sci. Launches Phase II Trial of AST-201 in Homologous Recombination-Proficient Ovarian Cancer
The US Food and Drug Administration cleared the firm's IND, allowing it to begin a US-based randomized trial of the investigational plasmid-based vaccine.
Blood-Based Omics Signatures Reflect 'Biological' BMI, Metabolic Health
Features found in the blood offered a more refined look at obesity and related conditions, shifting more readily than body mass index in response to lifestyle changes.
Leukemia Patients See Survival Benefit With Integrated Functional Drug, Molecular Testing Approach
Premium
Data presented at ASH's annual meeting showed that patients on matched drugs based on genomic sequencing and high-throughput drug testing lived longer than those who did not.
Breast, Ovarian Cancer Study Finds Ties Between Types of BRCA Alterations, Treatment Response
Breast and ovarian cancers with BRCA1 promoter methylation changes showed poorer chemotherapy responses than those with genetic alterations in BRCA1 or BRCA2.